Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice (2021)
- Authors:
- Puhl, Ana C.
- Gomes, Giovanni Freitas
- Damasceno, Samara
- Fritch, Ethan J.
- Levi, James A.
- Johnson, Nicole J.
- Scholle, Frank
- Premkumar, Lakshmanane
- Hurst, Brett L.
- LeeMontiel, Felipe
- Veras, Flávio Protásio
- Batah, Sabrina Setembre
- Fabro, Alexandre Todorovic
- Moorman, Nathaniel J.
- Yount, Boyd L.
- Dickmander, Rebekah
- Baric, Ralph
- Pearce, Kenneth H.
- Cunha, Fernando de Queiroz
- Alves Filho, José Carlos Farias
- Cunha, Thiago Mattar
- Ekins, Sean
- USP affiliated authors: VERAS, FLÁVIO PROTÁSIO - FCFRP ; FABRO, ALEXANDRE TODOROVIC - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; GOMES, GIOVANNI FREITAS - FMRP ; DAMASCENO, SAMARA - FMRP ; BATAH, SABRINA SETEMBRE - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1101/2021.12.16.472155
- Subjects: ANTIVIRAIS; ANTINEOPLÁSICOS; CITOCINAS; COVID-19
- Keywords: Antiviral; SARS-CoV-2; Spike protein; Entrectinib; Vandetanib
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PUHL, Ana C. et al. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, p. 1-52, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.12.16.472155. Acesso em: 12 fev. 2026. -
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2021). Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, 1-52. doi:10.1101/2021.12.16.472155 -
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1101/2021.12.16.472155 -
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1101/2021.12.16.472155 - Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice
- Pyronaridine protects against SARS-CoV-2 infection in mouse
- Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-kB and oxidative stress
- Toll like receptor 9 deficiency in neutrophil improves sepsis outcome preventing down-regulation of CXCR2
- Splenectomy increases neutrophil migration but does not affect mortality in lethal sepsis
- Targeting IL-33/ST2 signaling: regulation of immune function and analgesia
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Targeting nitric oxide as a key modulator of sepsis, arthritis and pain
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
Informações sobre o DOI: 10.1101/2021.12.16.472155 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
